Učitavanje...
Ilixadencel – an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration
Intratumoral administration of an immune primer is a therapeutic vaccine strategy aimed to trigger dendritic cell (DC)-mediated cross-presentation of cell-associated tumor antigens to cytotoxic CD8(+) T cells without the need for tumor antigen characterization. The prevailing view is that these cros...
Spremljeno u:
| Izdano u: | Pharm Res |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer US
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6002422/ https://ncbi.nlm.nih.gov/pubmed/29904904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-018-2438-x |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|